Trademark: SCTbio 2261750
Word
SCTbio
ID
2261750
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
09 February 2022
Registration Date
09 February 2022
Renewal Date
09 February 2032
Owner(s)
Service
Davies Collison Cave Pty Ltd
Goods and Services:
Class 40:
Manufacture of cell therapy materials to the order and specification of others including filling; manufacture of viral and non-viral vectors to the order and specification of others; manufacture of cellular vaccines, CAR-T therapies, TCR-T therapies, or CAR-NK therapies to the order and specification of others.
Manufacture of cell therapy materials to the order and specification of others including filling; manufacture of viral and non-viral vectors to the order and specification of others; manufacture of cellular vaccines, CAR-T therapies, TCR-T therapies, or CAR-NK therapies to the order and specification of others.
Class 42:
Pharmaceutical research and development, namely for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, or CAR-NK therapies; scientific research and development, namely for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, or CAR-NK therapies; consultation in the field of pharmaceutical research and development, namely for cell therapy material materials, cellular vaccines, CAR-T therapies, TCR-T therapies, or CAR-NK therapies; product research and development, namely for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, or CAR-NK therapies; biological materials testing services and biological laboratory services, namely for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, or CAR-NK therapies; contract research services in the field of cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, or CAR-NK therapies.
Pharmaceutical research and development, namely for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, or CAR-NK therapies; scientific research and development, namely for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, or CAR-NK therapies; consultation in the field of pharmaceutical research and development, namely for cell therapy material materials, cellular vaccines, CAR-T therapies, TCR-T therapies, or CAR-NK therapies; product research and development, namely for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, or CAR-NK therapies; biological materials testing services and biological laboratory services, namely for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, or CAR-NK therapies; contract research services in the field of cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, or CAR-NK therapies.